The Precision Peptide Company Appoints Certified Peptide Therapist and Integrative Health Coach Diane Stafrace to Advisory Board

Vancouver, British Columbia — July 3, 2026 — The Precision Peptide Company Inc., a publicly traded wellness enterprise focused on developing next-generation peptide formulations, has announced the appointment of Diane Stafrace to its Advisory Board. Stafrace, a Vancouver-based Certified Peptide Therapist and Integrated Health Coach, brings extensive hands-on experience in the peptide industry and a strong presence within the North American peptide wellness community.

Stafrace’s addition to the Advisory Board offers The Precision Peptide Company valuable insights from a practitioner’s perspective on how peptides operate in real-world health and wellness settings. Her work spans peptide therapy consulting, GLP-1 support, personalized nutrition, and behavior change coaching, with core philosophies aimed at addressing root causes of health issues and fostering sustainable wellness habits. Her practice, Get Set by Diane, is centered on designing personalized peptide protocols and wellness programs configured to optimize performance, recovery, longevity, and overall well-being.

The founder of Get Set by Diane, Stafrace’s credentials include certification in Peptide Therapy from Empowered Academy USA, Certified Integrative Health Coach from the Institute for Integrative Nutrition, as well as certifications as a Personal Trainer and Behaviour Change Specialist from the National Academy of Sports Medicine. She holds a B.Sc. in Mass Communications from the University of Malta. Her prior experience includes five years as a medical representative, which has provided her with a solid foundation in the OTC and broader healthcare sector, reinforcing her integrative approach to health and wellness today.

Stafrace’s holistic, personalized approach to health aligns with the company’s strategic focus on expanding consumer education regarding peptide-based wellness solutions. As demand grows for products in this space, her perspectives are expected to support the company’s efforts in market positioning and consumer engagement. The company’s CEO, Pratap Sandhu, commented that Stafrace’s practical insights will be crucial as the company advances its initiatives to scale up operations and product offerings in the wellness sector, particularly in categories such as recovery, performance, immunity, and longevity.

Diane Stafrace expressed her enthusiasm about joining the company’s advisory team, noting the potential of peptides as impactful tools in wellness. She highlighted that Precision Peptide’s commitment to science, testing, and advanced delivery systems—engineered for optimal absorption—resonates with her approach and aspirations within the industry. Her involvement is anticipated to bolster the company’s research, product development, and consumer education strategies amid a rapidly expanding market for peptide-based health solutions.

The Precision Peptide Company emphasizes its innovative approach, combining scientific formulation with innovative delivery technologies. Its products, manufactured in an approved U.S. facility, are distributed across North America, positioning itself as a key player at the intersection of biotechnology and consumer wellness. With a focus on high-quality peptide formulations, the company aims to meet the increasing market demand for effective, science-backed wellness products.

For more information, please visit www.precisionpeptidecompany.com.

Source: The Precision Peptide Company